Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1)  by Kuusniemi, A.-M. et al.
Glomerular sclerosis in kidneys with congenital
nephrotic syndrome (NPHS1)
A-M Kuusniemi1, J Merenmies1, A-T Lahdenkari1, C Holmberg1, K Salmela2, R Karikoski1, J Rapola1 and
H Jalanko1
1Hospital for Children and Adolescents and Biomedicum Helsinki, University of Helsinki, Helsinki, Finland and 2Kidney Transplantation
Unit, Helsinki University Hospital, Helsinki, Finland
Congenital nephrotic syndrome of the Finnish type (NPHS1)
is a rare genetic disease caused by mutations in the NPHS1
gene encoding a major podocyte slit-diaphragm protein,
nephrin. Patients with NPHS1 have severe nephrotic
syndrome from birth and develop renal fibrosis in early
childhood. In this work, we studied the development of
glomerular sclerosis in kidneys removed from 4- to
44-month-old NPHS1 patients. The pathological lesions and
expression of glomerular cell markers were studied in
nephrectomized NPHS1 and control kidneys using light and
electron microscopy and immunohistochemistry. An analysis
of 1528 glomeruli from 20 patients revealed progressive
mesangial sclerosis and capillary obliteration. Although few
inflammatory cells were detected in the mesangial area,
paraglomerular inflammation and fibrosis was common. The
podocytes showed severe ultrastructural changes and
hypertrophy with the upregulation of cyclins A and D1.
Podocyte proliferation, however, was rare. Apoptosis was
hardly detected and the expression of antiapoptotic B-cell
lymphoma-2 and proapoptotic p53 were comparable to
controls. Moderate amounts of podocytes were secreted into
the urine of NPHS1 patients. Shrinkage of the glomerular tuft
was common, whereas occlusion of tubular opening or
protrusion of the glomerular tuft into subepithelial space
or through the Bowman’s capsule were not detected. The
results indicate that, in NPHS1 kidneys, the damaged
podocytes induce progressive mesangial expansion and
capillary obliteration. Podocyte depletion, glomerular tuft
adhesion, and misdirected filtration, however, seem to play
a minor role in the nephron destruction.
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Constant proteinuria is known to result in glomerular
sclerosis and tubulointerstitial fibrosis, often gradually
leading to terminal renal failure.1 Recent studies have
indicated that injury in glomerular epithelial cells (podo-
cytes) leads to proteinuria and also triggers progressive
glomerular sclerosis. Mutations in genes encoding for
podocyte proteins such as podocin, CD2-associated protein
and a-actinin-4 result in proteinuria and the development of
lesions classified as focal segmental glomerulosclerosis
(FSGS).2,3 Congenital nephrotic syndrome caused by muta-
tions in WT1 gene, on the other hand, is associated with
diffuse mesangial sclerosis.4
In this work, we analyzed the glomerular changes in
kidneys with congenital nephrotic syndrome of the Finnish
type (CNF, NPHS1), which is a recessively inherited renal
disease caused by mutations in the nephrin gene.5 Nephrin is
a podocyte-specific protein located at the slit diaphragm of
kidney glomerulus. Many of the NPHS1 mutations, such as
Fin-major and Fin-minor, lead to the absence of nephrin and
severe nephrotic syndrome starting from the birth.6 The
NPHS1 kidneys show disrupted slit diaphragms and efface-
ment of podocyte foot processes seen in many other
proteinuric kidney diseases.6,7 Children with NPHS1 are
nephrectomized as infants (usually under the age of 1 year)
when the renal function is still well preserved. These kidneys
serve as a unique human material to study the development
of glomerulosclerosis. This is emphasized by the fact that the
basic defect is restricted to podocytes; it affects equally all
glomeruli and the scarring in NPHS1 kidneys progresses in a
fast manner as compared to many other disorders.
During the past years, proteinuria has been associated
with a number of morphologic variants of glomerular
sclerosis, both in human diseases and animal models.8,9
Also, a sequence of pathological events has been suggested,
which starts with podocyte depletion and formation of
glomerular tuft adhesions with Bowman’s capsule resulting in
misdirected filtration and destruction of the nephrons.10–12
Based on these findings, we were especially interested in the
lesions detectable in the endo- and extracapillary compart-
ments of NPHS1 glomeruli in the early phase of the sclerotic
process.
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RESULTS
The overall histology of the 49 NPHS1 kidneys nephrecto-
mized at the age of 4–44 months ranged from nearly normal
to severely damaged (Figure 1). The findings included
glomerular sclerosis, interstitial fibrosis and inflammation,
tubular atrophy and dilatation, and arterial wall thickening.
Variation in the rate of progression of the pathological lesions
was evident, so that fairly normal and totally sclerotic
glomeruli and tubuli could be seen next to each other (Figure
1a). Affected glomeruli were scattered around the whole
cortex, without predilection to juxtamedullary area as often
seen in FSGS. Clusters of inflammatory cells were common
around degenerating glomeruli in NPHS1 kidneys (Figures
1b, 2e, and 3j).
Mesangial expansion and capillary obliteration were early
and constant findings
Histopathology of 1528 glomeruli in 20 NPHS1 kidneys from
patients with different ages was systematically analyzed
(Figure 2). Mesangium was affected in practically every
glomerulus (99.7%), so that the lesions ranged from mild
widening of the mesangial stalk to total sclerosis (Figure
3a–e). The early lesions were scattered around the glomerular
tuft and consisted of increased number of mesangial cells and
matrix (Figure 3b). The number of proliferating cells, as
revealed by the MIB-1 staining, was increased in the NPHS1
(1.1470.44/glomerular gross section) as compared to con-
trols (0.270.14/GCS) (Po0.0005). On the other hand,
few terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL)-positive apoptotic cells were
present in the glomerular tuft both in NPHS1 kidneys and
controls (0.0170.01/GCS and 0.0770.07/GCS, respectively).
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Figure 1 | Progression of renal damage in NPHS1 kidneys.
(a) A typical finding in a fairly well-preserved NPHS1 kidney
(nephrectomized at the age of 7 months): one totally sclerosed
glomerulus (arrow) surrounded by several glomeruli with only mild
mesangial expansion. (b) Severe glomerular sclerosis, arterial wall
thickening, and tubulointerstitial damage in an NPHS1 kidney
removed at the age of 29 months. (c) Development of glomerular
sclerosis (scored 0–3) in 49 NPHS1 kidneys in relation to the patients
age at the time of nephrectomy. The rate of progression of glomerular
sclerosis varies considerably among the patients (r2¼ 0.40). (a and b;
PASM stainings, original magnification  50).
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Figure 2 | Glomerular histology in relation to the age of the patients at the time of nephrectomy. The results are based on a
semiquantitative analysis of glomerular histology (see Materials and Methods for more details). One thousand five hundred and twenty-eight
glomeruli from PASM-stained samples in kidneys of 20 patients (age 4–44 months) with NPHS1 were analyzed. (a) The proportion of glomeruli
with extensive mesangial sclerosis was higher in older kidneys. (b) The prevalence of wide urinary space was around 20% in all NPHS1 samples.
(c) A single-cell layer of PECs was found in over 99% of NPHS1 glomeruli. (d) There was great variation in the rate of Bowman’s capsule
thickening between the samples. (e) Development of periglomerular inflammatory cell infiltration had the strongest correlation with age
(r2¼ 0.79). (f) Periglomerular fibrosis surrounding the glomerulus did not correlate with age.
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Inflammatory cells were rare in the capillary tuft as
studied by immunohistochemistry, with a mean of 3.771.8
and 1.170.2 cells/GCS in NPHS1 and control kidneys,
respectively (Po0.05). The cells were mainly lymphocytes
with cells of the monocyte/macrophage lineage (expressing
CD14, CD13, and CD68 markers) as the second largest group
(Figure 4).
Obliteration of glomerular capillaries could be seen
already in glomeruli with mild and moderate mesangial
changes (Figure 5). Immunoperoxidase staining for the
endothelial marker CD34 clearly demonstrated a decrease
in the total endothelial surface area of the capillary tuft
(Po0.05) (Figure 5e) and narrowing of the capillary lumens
in NPHS1 kidneys as compared to controls (Po0.005)
(Figure 5f). Endothelial cell swelling was evident in direct
microscopy (Figure 6c and d), but capillary thrombosis or
hyaline occlusion was not seen among 230 NPHS1 glomeruli
from 11 patients studied with light microscopy of HE
staining. Collapse of the capillary tuft was evident in
glomeruli with severe mesangial lesions.
Podocytes showed phenotypic changes and hypertrophy, but
little proliferation or apoptosis
Podocytes in NPHS1 kidney show marked structural changes
as shown previously.7 Prominent podocyte cell bodies with
microvillous degeneration, elongated primary processes, and
foot process effacement was most evident in scanning
electron microscopy (Figure 6a and b). Also in light
microscopy, podocytes in NPHS1 kidneys looked hyper-
trophic with prominent nucleus (Figure 6c and d).
The number of WT1-positive cells (podocytes) in well-
preserved NPHS1 glomeruli was similar to controls
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Figure 3 | Light microscopic findings in NPHS1 kidneys. (a) Control kidney glomerulus with normal mesangium. (b–e) A series of NPHS1
glomeruli with increasing amount of mesangial sclerosis. Some degree of mesangial sclerosis was found in 99.7% of NPHS1 glomeruli.
(f) Urinary space (Bowman space) was wide in 18% of NPHS1 glomeruli analyzed. Hypertrophic single-cell layer was observed in 9% of the
glomeruli, and in 87% of these glomeruli, the Bowman’s basement membrane was thickened. (g) There were very few tip lesions and
no peritubular changes in NPHS1 glomeruli. (h and i) High-magnification images showing a common finding in NPHS1 and control
kidneys: glomerular tuft seems to be in contact with the Bowman’s capsule (arrows). (j) Correlation of the mesangial sclerosis with
periglomerular fibrosis and inflammation. (a–i; PASM stainings, original magnification  200 in (a)–(g) and  500 in (h) and (i)).
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(33.275.5 and 36.372.8/GCS, respectively) (Figure 7a–c).
The area fraction of the podocyte intermediate filament,
vimentin, was slightly reduced in NPHS1 glomeruli with
mild lesions as compared to controls (Figure 7d–f). In clearly
sclerotic glomeruli, the expression of both markers was
decreased indicating podocyte loss (Figure 7c and f).
The number of MIB-1-positive proliferating extracapillary
cells was low (0.08/GCS) in NPHS1 kidneys (Table 1, Figure
8a). Also, podocyte layer hyperplasia, as seen in collapsing
glomerulopathy, was suspected in only 11 of 1528 (1%)
NPHS1 glomerular cross-sections, all of them showing severe
mesangial lesions.
Even though podocyte proliferation was nearly absent,
there was upregulation of cell cycle promoters cyclin A and
especially cyclin D1 and downregulation of cell cycle kinase
inhibitor p57 in NPHS1 compared to controls (Table 1,
Figure 8c–h). This indicates that podocytes were in a
hypertrophic state, which was also supported by the findings
in light microscopy (see above).
Apoptosis of podocytes was not prominent, as no
TUNEL-positive extracapillary cells were found in NPHS1
glomeruli (Table 1, Figure 8b). In accordance with this, no
extracapillary cells with condensed nuclei (apoptosis or
mitosis) were detected in NPHS1 glomeruli (Table 1).
Although the expression of proapoptotic p53 was not
increased in the extracapillary cells (Table 1, Figure 8i and
j), the number of cells expressing the antiapoptotic B-cell
lymphoma-2 was slightly but not significantly higher in
NPHS1 glomeruli (0.05/GCS) than in controls (0.01/GCS)
(P¼NS) (Table 1, Figure 8k and l).
Possible detachment of podocytes was evaluated by
counting WT1-positive cells in tubular lumens of formalin-
fixed tissue samples. There were no WT1-positive cells in
2130 NPHS1 and 1280 control tubular cross-sections.
Excretion of podocytes into voided urine was analyzed using
immunofluorescence staining of podocalyxin and ZO-1-
positive cells and granules in 18 (of which 15 were used in
immunohistology double stainings) urine samples from
NPHS1 patients (age range 3–10 months) and 12 control
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Figure 4 | Light microscopy and immunoperoxidase staining of
inflammatory cells in NPHS1 and control glomeruli. There was an
average of 3.7 and 1.1 inflammatory cells per glomerular cross-
section in NPHS1 and control kidneys, respectively. (a) The numbers
of different inflammatory cell types in NPHS1 (’) and control (&)
glomeruli. (b) CD3-positive T-lymphocytes were the largest group,
followed by (c) CD20-positive B-lymphocytes. The cells of monocyte/
macrophage lineage including (d) CD14-positive cells were the
second largest group after lymphocytes. Smaller amounts of
(e) neutrophils, mast cells (mast cell Tryptase), and eosinophils
were present. Original magnification  200.
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Figure 5 | Capillary changes in NPHS1 glomeruli. (a–d) Immuno-
peroxidase staining of endothelial cell marker CD34 showing
narrowing of the capillary lumen in NPHS1 kidneys as compared to
controls. (e) The area fraction of CD34 demonstrating the amount
of endothelium present in a glomerulus was significantly lower in
NPHS1 than in control glomeruli. (f) Also, the area fraction of areas
inside the CD34-stained capillary walls was significantly lower in
NPHS1 glomeruli. The area fractions were calculated from a total
of 210 glomeruli. Original magnification  200.
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samples. Urine from NPHS1 patients contained more
podocalyxin-positive cells (median 15.9 vs 0.7 cells/ml) and
granules (total scores: 24.9 vs 1.5) than control urine samples
(Figure 9a, c, and e). Double immunostaining for podo-
calyxin and ZO-1 revealed a median of 13.9 and 0.3 co-
positive cells in NPHS1 and control urine samples,
respectively (Figure 9b, d, and f).
Parietal epithelial cells were resistant to protein overload
Parietal epithelial cell (PEC) layer looked normal in 91%
(1097/1205) of the glomeruli that were included in the
analysis. Hypertrophic single-cell layer was observed in 9% of
the glomeruli, mostly (87%) in association with thickened
basement membrane (Figure 3f). Only one glomerulus with
more than one PEC layer was observed. Eighteen and five
PECs with condensed nucleus (apoptosis/mitosis) per 100
glomeruli were observed in NPHS1 and controls, respectively
(Po0.05). PECs positive for the proliferation marker MIB-1
were somewhat more frequent in NPHS1 kidneys than
controls (18 vs 3 per 100 glomeruli, P¼NS). On the other
hand, only one TUNEL-positive apoptotic PEC was found in
836 NPHS1 glomeruli. The results indicate that PECs were
quite resistant to the unusually high protein concentration of
the primary filtrate.
No protrusion of the capillary tuft into peritubular or
periglomerular spaces was observed
Urinary space (Bowman space) was wide in 18% (221/1227)
of the NPHS1 glomeruli (Figure 2b). Two-thirds of these
showed at least moderate sclerosis, suggesting that the wide-
ning was caused by shrinkage of the glomerular tuft. This was
supported by the fact that the average area of glomeruli
with normal (n¼ 204) and wide urinary space (n¼ 103)
was quite similar (1183571972 vs 1351673021 pixels;
P¼NS), respectively.
Contact of the capillary tuft with the Bowman’s capsule
was quite common both in NPHS1 and control kidneys
(Figure 3h and i). Protrusion of the capillary tuft through
Bowman’s capsule, however, was not seen in any of the 1415
glomeruli specifically analyzed. Adhesion of the capillary tuft
and Bowman’s capsule at the tubular opening (tip lesion) was
suspected in only four of the 207 (2%) glomeruli in which
tubular opening was visible (Figure 3g). Similarly, separation
a b
c d
Figure 6 | Podocytes in NPHS1 glomeruli. (a, b) Scanning electron
microscopy of NPHS1 glomeruli showing prominent cell bodies,
abundant microvillar structures, long primary processes (white
arrow), and foot process effacement. (c) Light microscopy of NPHS1
kidneys showing podocytes with large, hypertrophied cell bodies and
larger nuclei that were located far from the basement membrane
(arrowheads). Endothelial cells were also hypertrophic in NPHS1
glomeruli (arrows). (d) Normal podocytes (arrowheads) and
endothelial cells (arrows) in a control kidney. (c and d; PASM
stainings, original magnification  500).
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Figure 7 | The expression of WT1 and vimentin in NPHS1 and control kidneys. (a–c) The number of WT1-positive cells per glomerular
cross-section in NPHS1 and control kidneys. (d–f) Area fraction of vimentin staining in NPHS1 kidneys. Original magnification  200.
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of tubular basement membrane from its epithelium and
formation of a peritubular space was not seen among the
tubular openings observed. Segmental crescent was seen in
only 0.5% (5/1156) of the glomeruli analyzed.
DISCUSSION
We evaluated the development glomerular lesions in NPHS1
kidneys lacking the major podocyte slit-diaphragm protein
nephrin. The analysis indicated that constant heavy protein-
uria in these kidneys inevitably resulted in total glomerular
sclerosis and destruction of the nephrons. The progression
rate varied from nephron to nephron, suggesting that protein
leakage, affecting equally all glomeruli, was not the only
contributing factor for sclerosis. Impact of the damaged
podocytes on the mesangial and endothelial cells was most
probably crucial for the pathological process.
The most constant glomerular finding was mesangial
sclerosis as reported previously.13,14 Accumulation of extra-
cellular matrix proteins and cells in the mesangium was evi-
dent in practically every glomerulus. Immunohistochemistry
Table 1 | Expression of markers for cell cycle and apoptosis in NPHS1 and control glomerulia
NPHS1 Control P-value
MIB-1 0.0870.07 (25/354) 0.0370.02 (5/180) NS
TUNEL 0 (0/658) B0 (1/240) NS
Condensed nucleus 0 (0/635) B0 (2/414) NS
p57b 17.8372.75 (2852/160) 24.3873.51 (2438/100) 0.003
Cyclin A 0.0370.03 (20/582) 0 (0/310) 0.04
Cyclin D1 0.5170.32 (157/337) 0.1070.16 (18/224) 0.03
p53 0.0670.08 (19/351) 0.0170.01 (1/164) NS
Bcl-2 0.0570.04 (20/378) 0.0170.01 (3/281) NS
Abbreviations: Bcl, B-cell lymphoma; MIB, mind bomb homolog; NPHS1, nephrotic syndrome of the Finnish type; NS, nonsignificant; TUNEL, terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling.
aResults are expressed as the mean7s.d. of positive cells per glomerular cross-section. In parenthesis: positive cells/glomerular cross-sections examined. Positive extracapillary
cells counted only (except in the case of p57).
bAll p57-positive glomerular cells counted, as p57 is expressed only in podocytes.
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Figure 8 | Cell cycle markers of extracapillary cells in NPHS1 and control glomeruli. (a) There were very few (0.08/GCS) proliferating
extracapillary cells (arrow) in NPHS1 kidneys based on the expression of MIB-1. (b) Apoptosis was even more uncommon among extracapillary
cells in NPHS1. Few (0.01/GCS) TUNEL-positive cells (arrow) were however found within the tuft. (c) There were significantly less p57-positive
cells in NPHS1 than in (d) control glomeruli. (e–h) On the other hand, there were more cyclin A- and cyclin D1-positive extracapillary cells
in NPHS1 glomeruli than in controls (Po0.05). (i–l) On average, one p53- and one B-cell lymphoma-2-positive extracapillary cell was found
among 20 GCS. Although they were more frequent in NPHS1, the difference to controls was not statistically significant. (a and c–l;
immunohistochemical stainings). Original magnification  200.
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revealed that the glomerular tuft contained low numbers of
inflammatory cells, indicating that the increased cellularity
was caused by reactive mesangial cells. Especially the low
number of monocytes/macrophages was interesting, as these
cells have been suggested to play a central role in crescent
formation and glomerulosclerosis.15,16 The early lesions in
the glomerular tuft did not show predilection to perihilar or
urinary pole, as is the case in some types of FSGS.17,18 Also,
tip lesions, that would occlude the opening of the tubular
lumen, were practically non-existing in NPHS1 kidneys.
Mesangial lesions were associated with obliteration of the
glomerular capillaries. This was observed in the direct
microscopy and immunohistochemical staining and was
evident already in glomeruli with mild lesions. Also, the
thickening of arteriolar walls in NPHS1 kidneys is a constant
finding19 and further highlights the important role of
defective blood circulation in the scarring process.20,21
Based on morphological analyses of FSGS kidneys, Kriz
and others.10–12 have developed a widely accepted theory that,
in proteinuric kidneys, apoptosis or detachment of podocytes
lead to denuded areas of glomerular basement membrane,
which adhere to the Bowman’s capsule. This then results in
misdirected filtration of urine into the paraglomerular and
paratubular space, finally leading to nephron loss.10–12 This
‘podocyte depletion’ theory is supported by findings that
podocytes are found in the urine from patients and
experimental animals with proteinuria.22–28
In NPHS1 kidneys, podocytes undoubtedly play a major
role both in the protein leakage and in triggering the sclerotic
process. Our previous electron microscopic analysis7 and the
results in this work, however, suggest that it may not be
question of simple ‘podocyte depletion’, but rather a more
complex interplay of podocytes with mesangial and en-
dothelial cells. Similar phenomena have been observed in rats
with anti-Thy 1.1 glomerulonephritis when treated with
puromycin aminonucleoside injections as well as in trans-
genic mice where podocyte damage has been caused by a
podocyte-specific immunotoxin.29,30 Podocytes in NPHS1
kidneys undergo phenotypic changes, such as foot process
effacement, which is typical for nephrotic diseases. They also
show hypertrophy, which was evident both in electron and
light microscopy and further supported by the findings that
upregulation of cell cycle promoters cyclin A and D1, and
downregulation of cell cycle kinase inhibitor p57 (together a
sign of hypertrophic and hyperplastic phenotype) were found
in parallel with low rate of proliferation in podocytes.31
Importantly, the podocytes in NPHS1 kidneys did not
proliferate, as is the case in the collapsing variant of FSGS.32
Shedding of podocytes into urine is believed to reflect the
podocyte injury, and has been reported in several types of
human kidney diseases.24–28 Analysis of urine from NPHS1
patients revealed that the number of podocalyxin-positive
cells in NPHS1 patients (median 15.9 cells/ml) was quite
close to that previously found in patients with FSGS (4.2 and
1.3 cells/ml)25,26 and lupus nephritis (6.2 cells/ml).27 So, it
seems clear that podocytes detach from the glomerular
basement membrane in NPHS1 kidneys. Whether this
reflects some primary event or is a consequence of the
glomerular tuft damage remains to be solved.
We were especially interested in possible synechiae of the
glomerular (denuded) capillaries with the Bowman’s capsule
leading to misdirected filtration of capillary blood or urine.
Attachment of the glomerular tuft with the Bowman’s capsule
was frequently seen in NPHS1 and control kidneys in direct
microscopy and this finding was difficult to interpret.
However, if misdirected filtration and filtrate spreading were
an important early event leading to glomerular sclerosis and
nephron degeneration, segmental lesions should have been
seen in a substantial proportion of the hundreds of well-
preserved (functional) NPHS1 glomeruli analyzed. This was
clearly not the case. We found no local protrusions of the
glomerular tuft into the paratubular spaces or paraglomer-
ular space, as reported in FSGS.10–12
In conclusion, the results suggest that in NPHS1 kidneys
the role of mesangial sclerosis and stenosis of glomerular
capillaries are pivotal for the destruction of the glomerulus,
and possibly the downfall of the entire nephron. Which
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Figure 9 | Immunofluorescence staining of podocytes in the urine
of NPHS1 patients and controls. (a) Immunofluorescence for
podocalyxin in NPHS1 kidneys. Podocalyxin is found in podocytes
and endothelial cells. (b) ZO-1 is specific for podocytes in the
glomerulus. (c) Podocalyxin- and (d) ZO-1-positive cells in NPHS1
urine (images from immunofluorescence double staining). (e) Urine
from NPHS1 patients contained more podocalyxin-positive cells
(median 15.9 vs 0.7 cells/ml) than control urine samples. (f) Double
immunostaining for podocalyxin and ZO-1 revealed a median of 13.9
and 0.3 co-positive cells in NPHS1 and control urine samples,
respectively. The line indicates the median (in e and f). Original
magnification  200.
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mediators are important in the interplay of damaged
podocytes with mesangial and endothelial cells remains to
be solved.
MATERIALS AND METHODS
Tissue and urine samples
A total of 49 children with NPHS1 (age 4–44 months) were
nephrectomized at the Hospital for Children and Adolescents,
University of Helsinki, Finland, between the years 1986 and 2003.
Twenty-nine of the patients were homozygotes for Fin-major
mutation, nine had Fin-major/Fin-minor genotype and four were
Fin-minor homozygotes.5,6 In addition, one patient had Fin-major/
C465Y, one had Fin-major/IVS26-1 g-a, and one Fin-major/C465Y
genotype. No knowledge of the mutations in four samples was
available. All patients had a severe nephrotic syndrome from the
birth and were treated with daily albumin infusions to supplement
the continuous heavy protein losses.
Routine formalin-fixed paraffin-embedded samples were
prepared from the kidneys and the rest of the renal cortex
was snap-frozen in liquid nitrogen and stored at 701C. The
glomeruli for scanning electron microscopy were isolated under
dissection microscope and processed as described previously.7 As
controls, we used eight normal adult kidneys (age 47–58 years)
removed for transplantation. These kidneys proved unsuitable for
transplantation mainly because of vascular abnormalities. Formalin-
fixed paraffin-embedded sections and snap-frozen samples were
collected. The cadaver kidneys had to be used as controls, as fresh
tissue samples from normal infant kidneys were not possible to
obtain.
Fresh urine samples were obtained from four NPHS1 children
aged 3–10 months, five pediatric patients with normal kidney
function, and five healthy adults. Fifteen samples were collected
from NPHS1 children and 12 samples from the control group. The
urine specimens were processed within 2 h after voiding.33
The study protocol was approved by the ethical committee of the
Hospital for Children and Adolescents of the University of Helsinki
and conformed to the principles outlined in the Declaration of
Helsinki.
Antibodies
The following antibodies were purchased from Dako (Glostrup,
Denmark): B-cell lymphoma-2 (M0887), CD20cy (M0755), CD34
(M7165), CD68 (M0876), MIB-1 (M7240), p53 (M7001), and
vimentin (M7020). Antibodies against cyclin A (NCL-Cyclin A),
cyclin D1 (NCL-cyclin D1-GM), and WT1 (NCL-WT-1-6FH2) were
bought from Novocastra (Newcastle upon Tyne, UK). From Abcam
(Cambridge, Cambridgeshire, UK) were antibodies against CD3
(ab828) and CD14 (ab8679). Antibodies against CD13 (MS-1079)
and p57 (MS-1062-P) were bought from Neomarkers (Fremont,
CA, USA). In addition, we used mast cell tryptase (Mob 347)
(Diagnostic BioSystems, Pleasanton, CA, USA), podocalyxin
(AF1658) (R&D Systems, Minneapolis, MN, USA), and ZO-1
(61-7300) (Zymed Laboratories, San Francisco, CA, USA) antibodies.
All these primary antibodies were unconjugated, and dilutions
from 1:10 to 1:250 were used.
We used the following markers for different inflammatory cell
types: CD13 for monocytes, CD68 for macrophages, CD14 for
monocytes and macrophages and some of their subpopulations,
mast cell tryptase for activated mast cells, CD3 for T-lymphocytes,
and CD20cy for B-lymphocytes.
Light microscopy
The histological lesions in the NPHS1 glomeruli were evaluated by
light microscopy from paraffin-embedded tissue sections stained
with hematoxylin and eosin or periodic acid silver methenamin
(PASM). Glomerular sclerosis was correlated to the age at
nephrectomy in 49 NPHS1 kidneys as described previously (Figure
1c).19
The progression of glomerular damage was analyzed by grading
10 features of glomerular histology in 1528 glomeruli of 20 NPHS1
kidneys (age range 4–44 months, median age 8 months). The
parameters were: the increase of mesangial matrix and cell content,
the size of the urinary space, the thickness of the Bowman’s
basement membrane, the size of the mesangial hilus, hypertrophy
and the number of PEC, and the amount of periglomerular fibrosis
and periglomerular inflammation. In addition, the presence of
crescents, tipping of the glomerular tuft into the tubular pole,
peritubular changes, and a possible hyperplasia of the podocyte layer
were noted on each glomerulus.
Immunohistochemistry
For the immunofluorescence stainings, the cryosections (5mm) of
the kidney samples were fixed with 3.5% paraformaldehyde or
acetone, depending on the antibody used. The stainings were
performed in a traditional way. Sections used as negative controls
were incubated in phosphate-buffered saline instead of a primary
antibody. Podocalyxin and ZO-1-positive cells and granular material
in the urine sediments of NPHS1 patients and controls were studied
by immunofluorescence as described previously.28
Immunoperoxidase stainings were performed on the sections of
formalin-fixed, paraffin-embedded renal samples in a conventional
way. To improve antibody penetration, microwave treatment in
10 mM citric acid or Dako Target Retrieval Solution (Dako) were
used. Amplification of the primary antibody reaction was achieved
by incubating the sections with biotinylated secondary antibody
(Vector Laboratories Inc., Burlingame, CA, USA). Immunoperoxi-
dase staining of cryosections, fixed with 3.5% paraformaldehyde or
acetone, was performed similarly.
The image analysis program NIH ImageJ 1.32j (National
Institutes of Health, Bethesda, MD, USA) was used to calculate
the area fraction of a particular immunostained component. The
area fraction of capillary lumens was calculated using the same
program with a manual selection of the calculated area. The
proportion of black-to-white pixels in the image was calculated as a
percentage.34 All immunohistochemical data were analyzed from at
least five control and six NPHS1 kidneys.
TUNEL
The occurrence of apoptosis in glomerular cells was analyzed by
monitoring the presence of DNA fragmentation.35 Slides were
analyzed by light microscopy after counterstaining with hematox-
ylin. Cells exhibiting dark brown staining from the colorimetric
reaction were considered positive for DNA fragmentation. Nine
NPHS1 kidneys with a histology ranging from nearly normal to
severely damaged were analyzed together with five control kidneys.
As positive controls, we used testis samples with abundant
apoptosis.
Statistics
Data are presented as mean7s.d. Two-tailed P-values o0.05
(Student’s t-test) were considered significant.
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